hr-HPV testing in the follow-up of women with cytological abnormalities and negative colposcopy View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2013-09-05

AUTHORS

F Carozzi, C B Visioli, M Confortini, A Iossa, P Mantellini, E Burroni, M Zappa

ABSTRACT

Background:The follow-up after abnormal Pap smear and negative colposcopy is not clearly defined. This study aimed at investigating the role of hr-HPV testing in the management of abnormal Pap test and negative colposcopy for Cervical Intraepithelial Neoplasia grade 2 or worse (CIN2+).Methods:The study enroled 1029 women with abnormal screening cytology (years 2006–2010) and negative colposcopy for CIN2+, which subsequently performed a hr-HPV test. Incident CIN2+ lesions were identified through linkage with cancer registry, hospital discharge records, neoplastic pathology reports and the archive of screening programme (2006–2011).Results:During the follow-up, the cohort developed 133 CIN2+ lesions; only one among hr-HPV-negative women. The probability of developing CIN2+ on follow-up time was 0.44% (95% confidence interval (CI) 0.1–3.1) and 41.8% (95% CI 31.8–53.5) for hr-HPV-negative women and hr-HPV-positive women, respectively. A woman with a positive hr-HPV test had about 105 times higher probability of developing a CIN2+ lesion than a woman with a negative hr-HPV test (hazard ratio (HR)=104.5, 95% CI 14.5–755.1), adjusted for index Pap test result, age and cervix squamocolumnar junction visualisation.Conclusion:Our results confirm that hr-HPV testing is able to select the real group of women at risk of developing CIN2+ lesions in the follow-up of abnormal cytology and first negative colposcopy. More... »

PAGES

1766-1774

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/bjc.2013.519

DOI

http://dx.doi.org/10.1038/bjc.2013.519

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1013200871

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24008667


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cervical Intraepithelial Neoplasia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Colposcopy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytological Techniques", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA, Viral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Papillomaviridae", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Papillomavirus Infections", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Uterine Cervical Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vaginal Smears", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Analytical Cytology and Biomolecular Unit, Istituto per lo Studio e la Prevenzione Oncologica, 50139, Florence, Italy", 
          "id": "http://www.grid.ac/institutes/grid.417623.5", 
          "name": [
            "Analytical Cytology and Biomolecular Unit, Istituto per lo Studio e la Prevenzione Oncologica, 50139, Florence, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Carozzi", 
        "givenName": "F", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Clinical and Descriptive Epidemiology Unit, Istituto per lo Studio e la Prevenzione Oncologica, 50139, Florence, Italy", 
          "id": "http://www.grid.ac/institutes/grid.417623.5", 
          "name": [
            "Clinical and Descriptive Epidemiology Unit, Istituto per lo Studio e la Prevenzione Oncologica, 50139, Florence, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Visioli", 
        "givenName": "C B", 
        "id": "sg:person.01273124755.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01273124755.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Analytical Cytology and Biomolecular Unit, Istituto per lo Studio e la Prevenzione Oncologica, 50139, Florence, Italy", 
          "id": "http://www.grid.ac/institutes/grid.417623.5", 
          "name": [
            "Analytical Cytology and Biomolecular Unit, Istituto per lo Studio e la Prevenzione Oncologica, 50139, Florence, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Confortini", 
        "givenName": "M", 
        "id": "sg:person.0667445361.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0667445361.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Screening Unit, Istituto per lo Studio e la Prevenzione Oncologica, 50139, Florence, Italy", 
          "id": "http://www.grid.ac/institutes/grid.417623.5", 
          "name": [
            "Screening Unit, Istituto per lo Studio e la Prevenzione Oncologica, 50139, Florence, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Iossa", 
        "givenName": "A", 
        "id": "sg:person.01217101277.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01217101277.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Regional Reference Centre for Cancer Screening, Istituto per lo Studio e la Prevenzione Oncologica, 50139, Florence, Italy", 
          "id": "http://www.grid.ac/institutes/grid.417623.5", 
          "name": [
            "Regional Reference Centre for Cancer Screening, Istituto per lo Studio e la Prevenzione Oncologica, 50139, Florence, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mantellini", 
        "givenName": "P", 
        "id": "sg:person.01264312727.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01264312727.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Analytical Cytology and Biomolecular Unit, Istituto per lo Studio e la Prevenzione Oncologica, 50139, Florence, Italy", 
          "id": "http://www.grid.ac/institutes/grid.417623.5", 
          "name": [
            "Analytical Cytology and Biomolecular Unit, Istituto per lo Studio e la Prevenzione Oncologica, 50139, Florence, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Burroni", 
        "givenName": "E", 
        "id": "sg:person.01247427717.79", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01247427717.79"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Clinical and Descriptive Epidemiology Unit, Istituto per lo Studio e la Prevenzione Oncologica, 50139, Florence, Italy", 
          "id": "http://www.grid.ac/institutes/grid.417623.5", 
          "name": [
            "Clinical and Descriptive Epidemiology Unit, Istituto per lo Studio e la Prevenzione Oncologica, 50139, Florence, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zappa", 
        "givenName": "M", 
        "id": "sg:person.013651510165.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013651510165.31"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s10096-012-1582-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024697107", 
          "https://doi.org/10.1007/s10096-012-1582-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6605619", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032089809", 
          "https://doi.org/10.1038/sj.bjc.6605619"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2407-11-240", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011423851", 
          "https://doi.org/10.1186/1471-2407-11-240"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc2050", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023331795", 
          "https://doi.org/10.1038/nrc2050"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-1-4612-2042-8_4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1089735234", 
          "https://doi.org/10.1007/978-1-4612-2042-8_4"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2013-09-05", 
    "datePublishedReg": "2013-09-05", 
    "description": "Background:The follow-up after abnormal Pap smear and negative colposcopy is not clearly defined. This study aimed at investigating the role of hr-HPV testing in the management of abnormal Pap test and negative colposcopy for Cervical Intraepithelial Neoplasia grade 2 or worse (CIN2+).Methods:The study enroled 1029 women with abnormal screening cytology (years 2006\u20132010) and negative colposcopy for CIN2+, which subsequently performed a hr-HPV test. Incident CIN2+ lesions were identified through linkage with cancer registry, hospital discharge records, neoplastic pathology reports and the archive of screening programme (2006\u20132011).Results:During the follow-up, the cohort developed 133 CIN2+ lesions; only one among hr-HPV-negative women. The probability of developing CIN2+ on follow-up time was 0.44% (95% confidence interval (CI) 0.1\u20133.1) and 41.8% (95% CI 31.8\u201353.5) for hr-HPV-negative women and hr-HPV-positive women, respectively. A woman with a positive hr-HPV test had about 105 times higher probability of developing a CIN2+ lesion than a woman with a negative hr-HPV test (hazard ratio (HR)=104.5, 95% CI 14.5\u2013755.1), adjusted for index Pap test result, age and cervix squamocolumnar junction visualisation.Conclusion:Our results confirm that hr-HPV testing is able to select the real group of women at risk of developing CIN2+ lesions in the follow-up of abnormal cytology and first negative colposcopy.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/bjc.2013.519", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "109"
      }
    ], 
    "keywords": [
      "HR-HPV test", 
      "HR-HPV testing", 
      "negative colposcopy", 
      "HR-HPV", 
      "cervical intraepithelial neoplasia grade 2", 
      "HR-HPV negative women", 
      "positive HR-HPV test", 
      "negative HR-HPV test", 
      "abnormal Pap test", 
      "Pap test results", 
      "hospital discharge records", 
      "abnormal Pap", 
      "incident CIN2", 
      "positive women", 
      "abnormal cytology", 
      "HPV testing", 
      "negative women", 
      "Cancer Registry", 
      "Pap test", 
      "pathology reports", 
      "cytological abnormalities", 
      "CIN2", 
      "times higher probability", 
      "colposcopy", 
      "grade 2", 
      "lesions", 
      "discharge records", 
      "women", 
      "cytology", 
      "registry", 
      "cohort", 
      "abnormalities", 
      "testing", 
      "test", 
      "age", 
      "PAP", 
      "risk", 
      "study", 
      "report", 
      "high probability", 
      "group", 
      "management", 
      "records", 
      "role", 
      "test results", 
      "results", 
      "real groups", 
      "program", 
      "time", 
      "probability", 
      "visualisation", 
      "linkage", 
      "archives"
    ], 
    "name": "hr-HPV testing in the follow-up of women with cytological abnormalities and negative colposcopy", 
    "pagination": "1766-1774", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1013200871"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/bjc.2013.519"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24008667"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/bjc.2013.519", 
      "https://app.dimensions.ai/details/publication/pub.1013200871"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-06-01T22:11", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/article/article_611.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/bjc.2013.519"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bjc.2013.519'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bjc.2013.519'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bjc.2013.519'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bjc.2013.519'


 

This table displays all metadata directly associated to this object as RDF triples.

230 TRIPLES      22 PREDICATES      96 URIs      83 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/bjc.2013.519 schema:about N348b037a75104c1bb18aa46de2ff2c4c
2 N45ffd9e0b4b0417395f5d5c257c0bb16
3 N4e797bc319ec44aba7e65f85ce5424a0
4 N5476504c6e654d17a1938acc02964be2
5 N6a85ed32c75b441d907844a4d86acbc5
6 N750540d74c6c4be98d256e8426efe6b3
7 N9873b80d71b247acb844340aa2cf665d
8 Na89e9b198acf4e28ba406f6c4ab6514b
9 Ndc661c6ef24643f8ad234287e1d4aa99
10 Ne0f1bb6943b24c71bd79b67a212eb468
11 Ne7434e084469471680b8ab9965d67ff1
12 Nf0d8241c724646beb467c34586949fed
13 anzsrc-for:11
14 anzsrc-for:1117
15 schema:author N2b177f86fe35488eb914198ed08e827e
16 schema:citation sg:pub.10.1007/978-1-4612-2042-8_4
17 sg:pub.10.1007/s10096-012-1582-1
18 sg:pub.10.1038/nrc2050
19 sg:pub.10.1038/sj.bjc.6605619
20 sg:pub.10.1186/1471-2407-11-240
21 schema:datePublished 2013-09-05
22 schema:datePublishedReg 2013-09-05
23 schema:description Background:The follow-up after abnormal Pap smear and negative colposcopy is not clearly defined. This study aimed at investigating the role of hr-HPV testing in the management of abnormal Pap test and negative colposcopy for Cervical Intraepithelial Neoplasia grade 2 or worse (CIN2+).Methods:The study enroled 1029 women with abnormal screening cytology (years 2006–2010) and negative colposcopy for CIN2+, which subsequently performed a hr-HPV test. Incident CIN2+ lesions were identified through linkage with cancer registry, hospital discharge records, neoplastic pathology reports and the archive of screening programme (2006–2011).Results:During the follow-up, the cohort developed 133 CIN2+ lesions; only one among hr-HPV-negative women. The probability of developing CIN2+ on follow-up time was 0.44% (95% confidence interval (CI) 0.1–3.1) and 41.8% (95% CI 31.8–53.5) for hr-HPV-negative women and hr-HPV-positive women, respectively. A woman with a positive hr-HPV test had about 105 times higher probability of developing a CIN2+ lesion than a woman with a negative hr-HPV test (hazard ratio (HR)=104.5, 95% CI 14.5–755.1), adjusted for index Pap test result, age and cervix squamocolumnar junction visualisation.Conclusion:Our results confirm that hr-HPV testing is able to select the real group of women at risk of developing CIN2+ lesions in the follow-up of abnormal cytology and first negative colposcopy.
24 schema:genre article
25 schema:inLanguage en
26 schema:isAccessibleForFree true
27 schema:isPartOf N1f48d029a1bf44c4be7e1404490d1dc6
28 N3e8b9bc811a8457ca02bf6b9e22bd2cc
29 sg:journal.1017082
30 schema:keywords CIN2
31 Cancer Registry
32 HPV testing
33 HR-HPV
34 HR-HPV negative women
35 HR-HPV test
36 HR-HPV testing
37 PAP
38 Pap test
39 Pap test results
40 abnormal Pap
41 abnormal Pap test
42 abnormal cytology
43 abnormalities
44 age
45 archives
46 cervical intraepithelial neoplasia grade 2
47 cohort
48 colposcopy
49 cytological abnormalities
50 cytology
51 discharge records
52 grade 2
53 group
54 high probability
55 hospital discharge records
56 incident CIN2
57 lesions
58 linkage
59 management
60 negative HR-HPV test
61 negative colposcopy
62 negative women
63 pathology reports
64 positive HR-HPV test
65 positive women
66 probability
67 program
68 real groups
69 records
70 registry
71 report
72 results
73 risk
74 role
75 study
76 test
77 test results
78 testing
79 time
80 times higher probability
81 visualisation
82 women
83 schema:name hr-HPV testing in the follow-up of women with cytological abnormalities and negative colposcopy
84 schema:pagination 1766-1774
85 schema:productId N076f4a8fdd0f434abc494b83f2650a7c
86 Nb19ac150d2e842d79f40863781ba9f8e
87 Ndb898ece9e7a411fbecc14176118a033
88 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013200871
89 https://doi.org/10.1038/bjc.2013.519
90 schema:sdDatePublished 2022-06-01T22:11
91 schema:sdLicense https://scigraph.springernature.com/explorer/license/
92 schema:sdPublisher Nfcff8153730d4474a0d757febf744870
93 schema:url https://doi.org/10.1038/bjc.2013.519
94 sgo:license sg:explorer/license/
95 sgo:sdDataset articles
96 rdf:type schema:ScholarlyArticle
97 N05ccc3478d554358a71ac7aa15302c54 rdf:first sg:person.01264312727.77
98 rdf:rest N647e54229f8f4a06976e45abe6854b46
99 N076f4a8fdd0f434abc494b83f2650a7c schema:name dimensions_id
100 schema:value pub.1013200871
101 rdf:type schema:PropertyValue
102 N0a1cc0e4b51b47a99e5940c902006e41 rdf:first sg:person.01217101277.13
103 rdf:rest N05ccc3478d554358a71ac7aa15302c54
104 N1f48d029a1bf44c4be7e1404490d1dc6 schema:volumeNumber 109
105 rdf:type schema:PublicationVolume
106 N2b177f86fe35488eb914198ed08e827e rdf:first N3968e8a8b6bc4d0aa25ea1a4a83a8a85
107 rdf:rest Ne467ad37504849f4a6ef0cc1aec3e8b5
108 N348b037a75104c1bb18aa46de2ff2c4c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Adult
110 rdf:type schema:DefinedTerm
111 N3968e8a8b6bc4d0aa25ea1a4a83a8a85 schema:affiliation grid-institutes:grid.417623.5
112 schema:familyName Carozzi
113 schema:givenName F
114 rdf:type schema:Person
115 N3e8b9bc811a8457ca02bf6b9e22bd2cc schema:issueNumber 7
116 rdf:type schema:PublicationIssue
117 N45ffd9e0b4b0417395f5d5c257c0bb16 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Cytological Techniques
119 rdf:type schema:DefinedTerm
120 N4e797bc319ec44aba7e65f85ce5424a0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Humans
122 rdf:type schema:DefinedTerm
123 N5476504c6e654d17a1938acc02964be2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Uterine Cervical Neoplasms
125 rdf:type schema:DefinedTerm
126 N647e54229f8f4a06976e45abe6854b46 rdf:first sg:person.01247427717.79
127 rdf:rest N88f6c629d12c428e8b834b56104df33f
128 N6a85ed32c75b441d907844a4d86acbc5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Colposcopy
130 rdf:type schema:DefinedTerm
131 N6efce7320247403c90b80a8863d40777 rdf:first sg:person.0667445361.38
132 rdf:rest N0a1cc0e4b51b47a99e5940c902006e41
133 N750540d74c6c4be98d256e8426efe6b3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Papillomavirus Infections
135 rdf:type schema:DefinedTerm
136 N88f6c629d12c428e8b834b56104df33f rdf:first sg:person.013651510165.31
137 rdf:rest rdf:nil
138 N9873b80d71b247acb844340aa2cf665d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name DNA, Viral
140 rdf:type schema:DefinedTerm
141 Na89e9b198acf4e28ba406f6c4ab6514b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Cervical Intraepithelial Neoplasia
143 rdf:type schema:DefinedTerm
144 Nb19ac150d2e842d79f40863781ba9f8e schema:name pubmed_id
145 schema:value 24008667
146 rdf:type schema:PropertyValue
147 Ndb898ece9e7a411fbecc14176118a033 schema:name doi
148 schema:value 10.1038/bjc.2013.519
149 rdf:type schema:PropertyValue
150 Ndc661c6ef24643f8ad234287e1d4aa99 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Female
152 rdf:type schema:DefinedTerm
153 Ne0f1bb6943b24c71bd79b67a212eb468 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Middle Aged
155 rdf:type schema:DefinedTerm
156 Ne467ad37504849f4a6ef0cc1aec3e8b5 rdf:first sg:person.01273124755.36
157 rdf:rest N6efce7320247403c90b80a8863d40777
158 Ne7434e084469471680b8ab9965d67ff1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Papillomaviridae
160 rdf:type schema:DefinedTerm
161 Nf0d8241c724646beb467c34586949fed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Vaginal Smears
163 rdf:type schema:DefinedTerm
164 Nfcff8153730d4474a0d757febf744870 schema:name Springer Nature - SN SciGraph project
165 rdf:type schema:Organization
166 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
167 schema:name Medical and Health Sciences
168 rdf:type schema:DefinedTerm
169 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
170 schema:name Public Health and Health Services
171 rdf:type schema:DefinedTerm
172 sg:journal.1017082 schema:issn 0007-0920
173 1532-1827
174 schema:name British Journal of Cancer
175 schema:publisher Springer Nature
176 rdf:type schema:Periodical
177 sg:person.01217101277.13 schema:affiliation grid-institutes:grid.417623.5
178 schema:familyName Iossa
179 schema:givenName A
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01217101277.13
181 rdf:type schema:Person
182 sg:person.01247427717.79 schema:affiliation grid-institutes:grid.417623.5
183 schema:familyName Burroni
184 schema:givenName E
185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01247427717.79
186 rdf:type schema:Person
187 sg:person.01264312727.77 schema:affiliation grid-institutes:grid.417623.5
188 schema:familyName Mantellini
189 schema:givenName P
190 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01264312727.77
191 rdf:type schema:Person
192 sg:person.01273124755.36 schema:affiliation grid-institutes:grid.417623.5
193 schema:familyName Visioli
194 schema:givenName C B
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01273124755.36
196 rdf:type schema:Person
197 sg:person.013651510165.31 schema:affiliation grid-institutes:grid.417623.5
198 schema:familyName Zappa
199 schema:givenName M
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013651510165.31
201 rdf:type schema:Person
202 sg:person.0667445361.38 schema:affiliation grid-institutes:grid.417623.5
203 schema:familyName Confortini
204 schema:givenName M
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0667445361.38
206 rdf:type schema:Person
207 sg:pub.10.1007/978-1-4612-2042-8_4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1089735234
208 https://doi.org/10.1007/978-1-4612-2042-8_4
209 rdf:type schema:CreativeWork
210 sg:pub.10.1007/s10096-012-1582-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024697107
211 https://doi.org/10.1007/s10096-012-1582-1
212 rdf:type schema:CreativeWork
213 sg:pub.10.1038/nrc2050 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023331795
214 https://doi.org/10.1038/nrc2050
215 rdf:type schema:CreativeWork
216 sg:pub.10.1038/sj.bjc.6605619 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032089809
217 https://doi.org/10.1038/sj.bjc.6605619
218 rdf:type schema:CreativeWork
219 sg:pub.10.1186/1471-2407-11-240 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011423851
220 https://doi.org/10.1186/1471-2407-11-240
221 rdf:type schema:CreativeWork
222 grid-institutes:grid.417623.5 schema:alternateName Analytical Cytology and Biomolecular Unit, Istituto per lo Studio e la Prevenzione Oncologica, 50139, Florence, Italy
223 Clinical and Descriptive Epidemiology Unit, Istituto per lo Studio e la Prevenzione Oncologica, 50139, Florence, Italy
224 Regional Reference Centre for Cancer Screening, Istituto per lo Studio e la Prevenzione Oncologica, 50139, Florence, Italy
225 Screening Unit, Istituto per lo Studio e la Prevenzione Oncologica, 50139, Florence, Italy
226 schema:name Analytical Cytology and Biomolecular Unit, Istituto per lo Studio e la Prevenzione Oncologica, 50139, Florence, Italy
227 Clinical and Descriptive Epidemiology Unit, Istituto per lo Studio e la Prevenzione Oncologica, 50139, Florence, Italy
228 Regional Reference Centre for Cancer Screening, Istituto per lo Studio e la Prevenzione Oncologica, 50139, Florence, Italy
229 Screening Unit, Istituto per lo Studio e la Prevenzione Oncologica, 50139, Florence, Italy
230 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...